Arkadios Wealth Advisors Grifols Sa Transaction History

Arkadios Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$10.21 - $15.27 $17,540 - $26,233	-1,718 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$14.07 - $17.3 $10,693 - $13,148	760 Added 79.33%	1,718 $25,000
Q2 2021 Jul 28, 2021	BUY	$16.62 - $18.94 $4,803 - $5,473	289 Added 43.2%	958 $16,000
Q1 2021 Apr 26, 2021	BUY	$15.15 - $19.78 $9,377 - $12,243	619 Added 1238.0%	669 $11,000
Q4 2020 Feb 09, 2021	BUY	$16.86 - $19.67 $843 - $983	50 New	50 $0
Q2 2020 Aug 10, 2020	SELL	$18.24 - $21.45 $14,026 - $16,495	-769 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$16.28 - $25.63 $1,253 - $1,973	-77 Reduced 9.1%	769 $15.5 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $16,556 - $19,897	846 New	846 $19,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.